1. Home
  2. STRO vs BNED Comparison

STRO vs BNED Comparison

Compare STRO & BNED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STRO
  • BNED
  • Stock Information
  • Founded
  • STRO 2003
  • BNED 1965
  • Country
  • STRO United States
  • BNED United States
  • Employees
  • STRO N/A
  • BNED N/A
  • Industry
  • STRO Biotechnology: Biological Products (No Diagnostic Substances)
  • BNED Other Specialty Stores
  • Sector
  • STRO Health Care
  • BNED Consumer Discretionary
  • Exchange
  • STRO Nasdaq
  • BNED Nasdaq
  • Market Cap
  • STRO 292.6M
  • BNED 283.2M
  • IPO Year
  • STRO 2018
  • BNED N/A
  • Fundamental
  • Price
  • STRO $2.84
  • BNED $10.53
  • Analyst Decision
  • STRO Strong Buy
  • BNED Hold
  • Analyst Count
  • STRO 7
  • BNED 2
  • Target Price
  • STRO $12.14
  • BNED $125.00
  • AVG Volume (30 Days)
  • STRO 1.0M
  • BNED 466.0K
  • Earning Date
  • STRO 11-13-2024
  • BNED 01-04-2025
  • Dividend Yield
  • STRO N/A
  • BNED N/A
  • EPS Growth
  • STRO N/A
  • BNED N/A
  • EPS
  • STRO N/A
  • BNED N/A
  • Revenue
  • STRO $160,955,000.00
  • BNED $1,566,405,000.00
  • Revenue This Year
  • STRO N/A
  • BNED $5.54
  • Revenue Next Year
  • STRO N/A
  • BNED N/A
  • P/E Ratio
  • STRO N/A
  • BNED N/A
  • Revenue Growth
  • STRO 230.90
  • BNED 0.88
  • 52 Week Low
  • STRO $2.45
  • BNED $6.05
  • 52 Week High
  • STRO $6.13
  • BNED $226.00
  • Technical
  • Relative Strength Index (RSI)
  • STRO 41.69
  • BNED 51.01
  • Support Level
  • STRO $2.66
  • BNED $10.50
  • Resistance Level
  • STRO $2.86
  • BNED $11.69
  • Average True Range (ATR)
  • STRO 0.19
  • BNED 0.75
  • MACD
  • STRO 0.02
  • BNED 0.05
  • Stochastic Oscillator
  • STRO 78.00
  • BNED 45.34

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.

About BNED Barnes & Noble Education Inc

Barnes & Noble Education Inc is an operator of bookstores in college and university campuses across the United States. The company is also engaged in providing digital education services. It operates in three reportable segments that include Retail offers existing and prospective clients the flexibility of physical, virtual, or custom store solutions, and wholesale is comprised of the wholesale and virtual retail fulfillment, and support operations of the MBS subsidiary, also Corporate Services represent unallocated shared-service costs which include corporate level expenses and other governance functions, including executive functions, such as accounting, legal, treasury, information technology, and human resources. It earns majority of the revenue from Retail segment.

Share on Social Networks: